Key result
Angiotensin II and cAMP stimulate amino acid transport in cultured vascular smooth muscle cells.
Why the study?
The regulation of amino acid transport by angiotensin II and cyclic AMP in vascular smooth muscle cells was investigated to understand underlying mechanisms.
Angiotensin II stimulates amino acid transport in vascular smooth muscle cells via a calcium-dependent pathway and potentiates cAMP-stimulated transport.
No immediate clinical implications; leaves open in vivo relevance to vascular remodeling or hypertension.
The regulation of amino acid transport by angiotensin II (AII) and cyclic AMP (cAMP) was assessed in cultured vascular smooth muscle cells, using a nonmetabolizable amino acid, alpha-[3H]aminoisobutyric acid (AIB). An exposure time in excess of 2 h was required for AII to elicit a stimulatory response, the magnitude of which increased in a time-dependent manner for 12 h. AII-induced transport was blocked by [1-sarcosine, 8-isoleucine]AII, a competitive inhibitor of AII binding. The effect of AII was not abolished by downregulation protein kinase C with phorbol 12,13-dibutyrate or by use of a protein kinase C inhibitor, suggesting that transport in response to AII can be mediated by a protein kinase C independent pathway. In contrast, the elimination of calcium from the incubation medium reduced AII-stimulated AIB uptake. The calmodulin inhibitor N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide partially inhibited AIB uptake in response to AII, suggesting that calmodulin may be involved in the modulation of AII-stimulated amino acid transport. AIB transport was also increased by elevating intracellular cAMP levels via beta-adrenergic receptor stimulation, the use of a cAMP analog (N6-monobutyryl cAMP), or a phosphodiesterase inhibitor (3-isobutyl-1-methylxanthine) or by direct stimulation of adenylate cyclase with forskolin. cAMP-induced AIB transport was evident within 10 min and peaked within 1 h. At 1 h AII enhanced cAMP-stimulated AIB transport. A possible mechanism for this effect is suggested by the observation that AII potentiated cAMP production in response to isoproterenol and 3-isobutyl-1-methylxanthine.
No takes yet. Share an insight, caveat, or question.
McCumbee et al. (1996) studied this question. Angiotensin II and cyclic AMP was evaluated on Amino acid transport (alpha-[3H]aminoisobutyric acid uptake). In cultured vascular smooth muscle cells, angiotensin II and cyclic AMP stimulated amino acid transport, with angiotensin II potentiating cAMP production.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: